Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.
暂无分享,去创建一个
[1] J. Palmblad,et al. A novel leukotriene produced by stimulation of leukocytes with formylmethionylleucylphenylalanine. , 1982, The Journal of biological chemistry.
[2] G. Weissmann,et al. Leukotriene B4 and phosphatidic acid are calcium ionophores. Studies employing arsenazo III in liposomes. , 1982, The Journal of biological chemistry.
[3] Robert A. Lewis,et al. Bronchoconstrictor effects of leukotriene C in humans. , 1982, Science.
[4] D. Sok,et al. Enzymatic formation of 14,15-leukotriene A and C(14)-sulfur-linked peptides. , 1982, Biochemical and biophysical research communications.
[5] M. Anderson,et al. Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Dahlén,et al. Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey , 1982, Nature.
[7] B. Samuelsson,et al. Stimulation of human leukocyte degranulation by leukotriene B4 and its ω‐oxidized metabolites , 1981 .
[8] S. Hammarström. Metabolism of leukotriene C3 in the guinea pig. Identification of metabolites formed by lung, liver, and kidney. , 1981, The Journal of biological chemistry.
[9] K. Bernström,et al. Metabolism of leukotriene D by porcine kidney. , 1981, The Journal of biological chemistry.
[10] G. Hansson,et al. Leukotriene C4 stimulates TXA2 formation in isolated sensitized guinea pig lungs. , 1981, Biochemical pharmacology.
[11] J. Palmblad,et al. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. , 1981, Blood.
[12] S. Dahlén,et al. Rapid invivo metabolism of Leukotriene C3 in the monkey, Macacairus , 1981 .
[13] S. Hammarström. Conversion of dihomo-gamma-linolenic acid to an isomer of leukotriene C3, oxygenated at C-8. , 1981, The Journal of biological chemistry.
[14] S. Dahlén,et al. Identification and biological activity of novel ω‐oxidized metabolites of leukotriene B4 from human leukocytes , 1981 .
[15] B. Samuelsson,et al. Formation of novel hydroxylated eicosatetraenoic acids in preparations of human polymorphonuclear leukocytes , 1981, FEBS letters.
[16] S. Dahlén,et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Samuelsson,et al. Novel leukotrienes: products formed by initial oxygenation of arachidonic acid at C-15. , 1981, Biochemical and biophysical research communications.
[18] B. Samuelsson,et al. Transformation of 15‐hydroperoxy‐5,9,11,13‐eicosatetraenoic acid into novel leukotrienes , 1981, FEBS letters.
[19] S. Hammarström. Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3. , 1981, The Journal of biological chemistry.
[20] M. A. Bray,et al. LEUKOTRIENE B4: A MEDIATOR OF VASCULAR PERMEABILITY , 1981, British journal of pharmacology.
[21] T. Williams,et al. Control of vascular permeability by polymorphonuclear leukocytes in inflammation , 1981, Nature.
[22] M. Peck,et al. The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. , 1981, Prostaglandins.
[23] P. Cuatrecasas,et al. The production of 5-HETE and leukotriene B in rat neutrophils from carrageenan pleural exudates. , 1981, Prostaglandins.
[24] M. A. Bray,et al. Isomers of leukotriene B4 possess different biological potencies. , 1981, Prostaglandins.
[25] B. Samuelsson. The leukotrienes: a new group of biologically active compounds , 1981, Advances in prostaglandin and thromboxane research.
[26] E. Corey,et al. Leukotriene A. Isolation from human polymorphonuclear leukocytes. , 1980, The Journal of biological chemistry.
[27] O. Rådmark,et al. Leukotrience C4: isolation from human polymorphonuclear leukocytes , 1980 .
[28] B. Samuelsson,et al. Detection of leukotriene A4 as an intermediate in the biosynthesis of leukotrienes C4 and D4 , 1980, FEBS letters.
[29] Bengt Samuelsson,et al. Leukotrienes are potent constrictors of human bronchi , 1980, Nature.
[30] E. Corey,et al. Leukotriene B. Total synthesis and assignment of stereochemistry , 1980 .
[31] G. Girard,et al. The action of leukotriene B4 (LTB4) on the lung. , 1980, Prostaglandins and medicine.
[32] A. Ford-hutchinson,et al. The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages. , 1980, Prostaglandins.
[33] J. Palmblad,et al. Leukotriene B4: a highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes. , 1980, Acta physiologica Scandinavica.
[34] M. Huber,et al. Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187. , 1980, Prostaglandins.
[35] S. Dahlén,et al. Biological profile of leukotrienes C4 and D4. , 1980, Acta physiologica Scandinavica.
[36] B. Samuelsson,et al. Leukotriene A4: enzymatic conversion to leukotriene C4. , 1980, Biochemical and biophysical research communications.
[37] E. Goetzl,et al. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). , 1980, Journal of immunology.
[38] D. Sok,et al. Identification of the slow reacting substances from cat paws. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[39] Robert A. Lewis,et al. Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. , 1980, Biochemical and biophysical research communications.
[40] G. J. Blackwell,et al. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids , 1980, Nature.
[41] M. A. Bray,et al. Leukotriene B: a potential mediator of inflammation , 1980, The Journal of pharmacy and pharmacology.
[42] S. Hammarström. Leukotriene C5: a slow reacting substance derived from eicosapentaenoic acid. , 1980, The Journal of biological chemistry.
[43] R. Palmer,et al. Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species. , 1980, Prostaglandins.
[44] C. Rouzer,et al. Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. A. Bray,et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.
[46] R. Murphy,et al. Leukotrienes and Slow Reacting Substance of Anaphylaxis (SRS‐A) , 1980, Allergy.
[47] B. Samuelsson,et al. Identification of leukotriene C-1 as a major component of slow-reacting substance from rat mononuclear cells. , 1980, Journal of immunology.
[48] E. Corey,et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[49] E. Corey,et al. Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[50] H. Morris,et al. Structure of slow-reacting substance of anaphylaxis from guinea-pig lung , 1980, Nature.
[51] F. Hirata,et al. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[52] B. Samuelsson,et al. Nomenclature for leukotrienes. , 1980, Prostaglandins.
[53] B. Samuelsson,et al. Identification of a component of rat mononuclear cell SRS as leukotriene D. , 1980, Biochemical and biophysical research communications.
[54] B. Samuelsson,et al. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[55] E. Corey,et al. Stereochemistry of leukotriene C-1. , 1980, Biochemical and biophysical research communications.
[56] E. Corey,et al. Leukotriene A: stereochemistry and enzymatic conversion to leukotriene B. , 1980, Biochemical and biophysical research communications.
[57] B. Samuelsson,et al. The inhibitory effects of BW 755C on arachidonic acid metabolism in human polymorphonuclear leukocytes , 1980, FEBS letters.
[58] H. Morris,et al. Slow reacting substances (SRSs): the structure identification of SRSs from rat basophil leukaemia (RBL-1) cells. , 1980, Prostaglandins.
[59] E. Corey,et al. Structure of leukotriene C. Identification of the amino acid part. , 1979, Biochemical and biophysical research communications.
[60] E. Corey,et al. Total synthesis of (.+-.)-5,6-oxido-7,9-trans,11,14-cis-eicosapentaenoic acid, a possible precursor of SRSA , 1979 .
[61] R. Murphy,et al. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[62] B. Samuelsson,et al. Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds. , 1979, The Journal of biological chemistry.
[63] B. Samuelsson,et al. Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Murphy,et al. Introduction of a nomenclature: leukotrienes. , 1979, Prostaglandins.
[65] B. Samuelsson,et al. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[66] B. Samuelsson,et al. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid. , 1979, The Journal of biological chemistry.
[67] M. Caton,et al. Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.
[68] K. Austen. Homeostasis of effector systems which can also be recruited for immunologic reactions. , 1978, Journal of immunology.
[69] H. Morris,et al. Slow‐reacting substance of anaphylaxis Purification and characterisation , 1978, FEBS letters.
[70] B. Jakschik,et al. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. K. Bach,et al. On the structure of slow reacting substance of anaphylaxis: evidence of biosynthesis from arachidonic acid. , 1977, Prostaglandins.
[72] M. Hamberg,et al. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. , 1976, The Journal of biological chemistry.
[73] L. Lichtenstein,et al. Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187. , 1976, Journal of immunology.
[74] L. Levine,et al. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[75] R. Orange,et al. The effect of thiols on the immunologic release of slow reacting substance of anaphylaxis. II. Other in vitro and in vivo models. , 1976, Journal of immunology.
[76] R. Korbut,et al. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig. , 1975, Prostaglandins.
[77] K. Austen,et al. Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases. , 1974, Journal of immunology.
[78] K. Austen,et al. The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. , 1973, Journal of immunology.
[79] K. Strandberg,et al. Purification and Properties of the Slow Reacting Substance Formed in the Cat Paw Perfused with Compound 48/801 , 1971 .
[80] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.
[81] K. Austen,et al. Slow reacting substance of anaphylaxis. , 1969, Advances in immunology.
[82] W. E. Brocklehurst. Slow reacting substance and related compounds. , 1962, Progress in allergy.
[83] Brock We. Occurrence of an unidentified substance during anaphylactic shock in cavy lung. , 1953 .
[84] E. R. Trethewie,et al. THE LIBERATION OF A SLOW‐REACTING SMOOTH MUSCLE‐STIMULATING SUBSTANCE IN ANAPHYLAXIS , 1940 .
[85] W. Feldberg,et al. Liberation of histamine and formation of lysocithin‐like substances by cobra venom , 1938, The Journal of physiology.